References
- Cartlidge NE, Whisnant JP, Elveback LR. Carotid and vertebral-basilar transient cerebral ischemic attacks. A community study, Rochester, Minnesota. Mayo Clin. Proc.52, 117–120 (1977).
- Heyman A, Wilkinson WE, Hurwitz BJ et al. Clinical and epidemiologic aspects of vertebrobasilar and nonfocal cerebral ischemia. In: Vertebrobasilar Arterial Occlusive Disease. Medical and Surgical Management. Berguer R, Bauer RB (Eds). Raven Press, NY, USA, 27–36 (1984).
- Whisnant JP, Cartlidge NE, Elveback LR. Carotid and vertebral-basilar transient ischemic attacks: effect of anticoagulants, hypertension, and cardiac disorders on survival and stroke occurrence – a population study. Ann. Neurol.3, 107–115 (1978).
- Flossmann E, Rothwell PM. Prognosis of vertebrobasilar transient ischaemic attack and minor stroke. Brain126, 1940–1954 (2003).
- Jones HR Jr, Millikan CH, Sandok BA. Temporal profile (clinical course) of acute vertebrobasilar system cerebral infarction. Stroke11, 173–177 (1980).
- Cross DT, Moran CJ, Akins PT et al. Collateral circulation and outcome after basilar artery thrombolysis. Am. J. Neuroradiol.19, 1557–1563 (1998).
- Devuyst G, Bogousslavsky J, Meuli R et al. Stroke or transient ischemic attacks with basilar artery stenosis or occlusion clinical patterns and outcome. Arch. Neurol.59, 567–573 (2002).
- Patrick BK, Ramirez-Lassepas M, Synder BD. Temporal profile of vertebrobasilar territory infarction. Prognostic implications. Stroke11, 643–648 (1980).
- Kasner SE, Lynn MJ, Chimowitz MI et al. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology67(7), 1275–1278 (2006).
- Berguer R, Morasch MD, Kline RA. A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease. J. Vasc. Surg.27, 852–859 (1998).
- Berguer R, Flynn LM, Kline RA, Caplan L. Surgical reconstruction of the extracranial vertebral artery: management and outcome. J. Vasc. Surg.31, 9–18 (2000).
- Jenkins JS, Patel SN, White CJ et al. Endovascular stenting for vertebral artery stenosis. J. Am. Coll. Cardiol.55, 538–542 (2010).
- Coward LJ, Featherstone RL, Brown MM. Percutaneous transluminal angioplasty and stenting for vertebral artery stenosis. Cochrane Database Syst. Rev.2, CD000516 (2005).
- Teraa M, Moll FL, van der Worp BH et al. Symptomatic vertebral artery stent fracture: a case report. J. Vasc. Interv. Radiol.21(11), 1751–1754 (2010).
- SSYLVIA Study Investigators. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results. Stroke35, 1388–1392 (2004).
- Stone GW, Ellis SG, Cox DA et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N. Engl. J. Med.350, 221–231 (2004).
- Ogilvy CS, Yang X, Natarajan SK et al. Restenosis rates following vertebral artery origin stenting: does stent type make a difference? J. Invasive Cardiol.22, 119–124 (2010).
- Steinfort B, Ng PP, Faulder K et al. Midterm outcomes of paclitaxel-eluting stents for the treatment of intracranial posterior circulation stenoses. J. Neurosurg.106, 222–225 (2007).
- Vajda Z, Miloslavski E, Güthe T et al. Treatment of stenoses of vertebral artery origin using short drug-eluting coronary stents: improved follow-up results. AJNR Am. J. Neuroradiol.30, 1653–1656 (2009).
- Compter A, van der Worp HB, Schonewille WJ et al. VAST: Vertebral Artery Stenting Trial. Protocol for a randomised safety and feasibility trial. Trials9, 65 (2008).
Website
- ClinicalTrials.gov: Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial (2010) http://clinicaltrials.gov/ct2/show/NCT00576693